• Published 1 Feb 2024

CatSci to Attend RNA Leaders Europe Congress

  • Events

CatSci Ltd will be attending the RNA Leaders Europe Congress conference on 13th – 14th March 2024. Hosted at the Congress Centre Basel, this event will bring together key stakeholders to examine the current and future challenges and opportunities of RNA therapeutics. Facilitating two days of learning and networking, the conference aims to forge collaborations that will bring new discoveries to market.  

Our Oligonucleotide Group Lead, Dr Aled Williams, and our Business Development Manager, Ali Albeckai, will be attending this two-day conference. They are excited to network with like-minded individuals and explore how CatSci’s in-depth expertise enables the synthesis of all classes of therapeutics oligos, including siRNA, ASO, Gapmers and sgRNA, as well as GalNAc ligands and other conjugates at up to a 30g scale.  

Our in-depth expertise in oligonucleotide R&D and manufacturing goes hand-in-hand with our GMP-analytical services, method development, and CMC expertise, including process optimisation studies for each unit operation in the oligonucleotide manufacturing process, as well as DoE optimisation and Quality by Design. 

If you would like to book a meeting with Aled and Ali at RNA Leaders, get in touch here.

Resources & Insights

  • 12 Jun 2026
  • Joseph Renny, Simon N. G. Tyler
From Undruggable to Inevitable: Fifteen years of drug development — and what comes next 
  • Artificial Intelligence (AI)
  • Process R&D
  • Thought Leaders
  • 27 May 2026
Celebrating 15 Years of CatSci – From Catalysis to Integrated Drug Development Partner  
  • News
  • 11 May 2026
CatSci Achieves ISO 27001 Certification, Demonstrating its Commitment to Client Data Security
  • News
  • 1 Apr 2026
  • Jean-Baptiste Vendeville
De-Risking Suzuki Development Through Integrated HTE and DoE
  • Analytical Chemistry
  • Chemical Development
  • Design of Experiments
  • High Throughput Experimentation
  • HTE
  • Scale-up
  • Whitepapers
2 MB